Status:
UNKNOWN
Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
Lead Sponsor:
All India Institute of Medical Sciences
Collaborating Sponsors:
Indian Council of Medical Research
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
12-80 years
Phase:
PHASE2
PHASE3
Brief Summary
In India, majority of our patients have advanced hepatocellular carcinoma (HCC) at presentation and hence are unsuitable for the available curative treatment options. In such patients the treatment op...
Detailed Description
1\. Aim of the study: To see the efficacy of transarterial chemotherapy in prolonging the survival of patients with unresectable HCC when compared to oral chemotherapy 2. Diagnostic criteria o Cirrho...
Eligibility Criteria
Inclusion
- Patients above 12 years of age with performance status (PST) score of 0-2
- Unresectable HCC with underlying Child's A/B cirrhosis
- Blocked Main portal vein
- No history of drug allergy
- Informed written consent of patient.
Exclusion
- Child's C cirrhosis
- Performance status 3-5
- Extra hepatic disease
- Co-morbid illness like coronary artery disease, congestive heart failure, chronic renal failure etc
- Previous history of encephalopathy/ upper gastrointestinal bleed in the last six months
- Pregnancy
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2015
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT02240771
Start Date
January 1 2006
End Date
March 1 2015
Last Update
September 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AII India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India, 110029